Vor Ort
Merkzettel Warenkorb
  • Produktbild: Organ Transplantation 1990
  • Produktbild: Organ Transplantation 1990
Band 11

Organ Transplantation 1990

Aus der Reihe Developments in Surgery

49,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.10.2012

Herausgeber

G.M. Abouna + weitere

Verlag

Springer Netherland

Seitenzahl

583

Maße (L/B/H)

23,5/15,5/3,3 cm

Auflage

Softcover reprint of the original 1st ed. 1991

Sprache

Englisch

ISBN

978-94-010-5497-3

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.10.2012

Herausgeber

Verlag

Springer Netherland

Seitenzahl

583

Maße (L/B/H)

23,5/15,5/3,3 cm

Auflage

Softcover reprint of the original 1st ed. 1991

Sprache

Englisch

ISBN

978-94-010-5497-3

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Organ Transplantation 1990
  • Produktbild: Organ Transplantation 1990
  • One: Historical Reflections.- 1. Reflections on the development of organ transplantation.- Two: Immunology of Organ Transplantation.- 2. Cellular and molecular mechanisms of allograft rejection.- 3. What does the alloreactive T cell see?.- 4. HLA matching and organ transplantation.- 5. An effective strategy for transplantation of highly sensitized patients.- 6. Rapid lymphocyte crossmatching for renal transplantation.- Three: Organ Allograft Rejection.- 7. Fifteen-year experience with fine needle aspiration biopsies at the University of Helsinki.- 8. Study of antibody specificity in highly sensitized patients using human monoclonal antibody technology.- 9. Idiotypic-Antiidiotypic antibody interaction and renal transplant survival.- Four: Immunosuppression.- 10. Transplantation and blood transfusion in 1990.- 11. Quadruple-drug immunosuppressive induction treatments for immunological high-risk patients in cadaveric renal transplantation using poly-and monoclonal antibodies.- 12. Sequential combination immunotherapy for cadaveric renal transplantation: OKT3 versus rabbit ATG induction.- 13. Multi-organ transplant experience with OKT3 and strategies for use at the University of Cincinnati Medical Center.- 14. Cyclosporine withdrawal in renal transplant recipients maintained on azathioprine, prednisone and cyclosporine.- 15. Early experience with FK 506 in liver transplantation.- 16. Deoxyspergualin. A novel immunosuppressant: experimental and clinical studies.- 17. Preliminary results with FK 506 in pancreas grafting in a nonhuman primate model.- 18. The effect of DST on graft outcome — the Turkish experience.- 19. Induction of specific unresponsiveness (tolerance) to experimental and clinical allografts using polyclonal antilymphocyte serum and donor-specific bone marrow.- 20. Comparison of cyclosporine assays using radioimmunoassay, fluorescent polarization immunoassay and high-performance liquid chromatography.- Five: Renal Transplantation.- 21. Long-term outcome in renal transplantation.- 22. Ten-year experience with 500 renal transplants.- 23. Long-term results in recipients of cadaveric renal allografts under cyclosporine therapy.- 24. Transplantation of single and double kidneys from pediatric donors.- 25. ABO-incompatible living related donor transplantation.- 26. The use of single pediatric cadaver kidneys for transplantation into adult recipients.- 27. Living unrelated donor renal transplantation.- 28. Renal transplantation in Tunisia — a three-year experience.- 29. Renal transplantation in children.- 30. Kidney donors — long-term follow up.- 31. Current techniques for permanent vascular access surgery — experience with 930 procedures.- 32. Results of 319 consecutive renal transplants from living related and living unrelated donors in Iran.- Six: Liver Transplantation.- 33. Liver transplantation: current status.- 34. An overview of liver transplantation therapy for children.- 35. Current anesthetic management in clinical liver transplantation.- 36. Risk factors in adult liver transplant recipients.- 37. The concept of reduced-size liver transplantation, including split-liver and living related liver transplantation.- 38. Immunological factors contributing to outcome in liver transplantation.- 39. Transplantation for hepatobiliary malignancies.- 40. The diagnosis and management of massive blood loss during liver transplantation.- 41. Early clinical experience with cluster resection and transplantation for right upper quadrant abdominal malignancy.- Seven: Heart/Heart-Lung Transplants.- 42. Lung transplantation: current techniques and outcomes.- 43. Heart-lung transplantation at the University of Minnesota.- 44. Specificity and sensitivity of the cytoimmunological monitoring (CIM): differentiation between cardiac rejection, viral, bacterial, or fungal infection.- Eight: Pancreas Transplantation.- 45. International Pancreas Transplantation Registry report.- 46. Techniques and experience of pancreatic transplantation with bladder drainage.- 47. Pancreas transplantation in non-uremic diabetic recipients.- 48. Early observation with pancreas transplantation using the bladder drainage procedure.- 49. Results of pancreas transplantation with irradiated spleen and segment of duodenum.- 50. Experience with pancreas transplants from living related donors.- Nine: Islet Cell Transplantation.- 51. Islet transplantation — the world Transplant Registry.- 52. Prevention of rejection of islet allografts and xenografts without continuous immunosuppression of the recipients.- 53. Effect of islet transplantation on diabetic secondary complications.- 54. Does pretreatment of islets of Langerhans with deoxyguanosine improve allograft survival without immunosuppression?.- Ten: Bone Marrow Transplantation.- 55. Current status of allogeneic bone marrow transplantation.- 56. New approach to bone marrow transplantation in thalassemia.- 57. Autologous bone marrow transplantation as treatment for bad-risk first remission acute lymphoblastic leukaemia.- 58. Conditioning regimens in bone marrow transplantation.- 59. The antileukaemic action of melphalan and total body irradiation in bone marrow transplantation.- 60. Antifungal prophylaxis with fluconazole in bone marrow transplantation.- Eleven: Xeno-Transplantation.- 61. Mass islet isolation from the pancreas of higher mammals: a potential source for islet transplantation in diabetic patients.- 62. The relationship of eicosanoids and complement components to hyperacute xenogeneic rejection and its modification by the PAF-antagonist WEB 2086BS.- 63. Antibody-induced rejection of established pig proislet xenografts in CD4+ T cell depleted diabetic mice.- Twelve: Complications in Organ Transplantation.- 64. Occurrence of malignancies in immunosuppressed organ transplant recipients.- 65. Transmission of cancer with donor organs.- 66. Long-term experience with surgical repair for transplant renal artery stenosis.- 67. Lymphoproliferative disorders after liver transplantation (OLT): a recent experience.- 68. Experience with Kaposi’s sarcoma in recipients of renal transplants in Tunisia.- 69. Urological complications in 510 consecutive renal transplants.- Thirteen: Organ Procurement and Preservation.- 70. Preservation of the kidney and other organs into the nineties.- 71. Clinical experience with liver preservation.- 72. Management of the organ donor.- 73. The role of the National Kidney Foundation in cadaveric transplantation in Saudi Arabia.- Fourteen: Ethical, Legal and Religious Aspects.- 74. The position of the Transplantation Society on commercialization in organ transplantation.- 75. Ethics and transplantation: an analysis of ‘rewarded gifting’.- 76. Moral, ethical and medical values sacrificed by commercialization in human organs.- 77. Commerce and trade in human organs.- 78. Some ethical concerns in organ transplantation.- 79. Islamic view on organ transplantation.- Index of subjects.